Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden

Wlodarczyk, J., Hunsche, E., Silberberg, B. et al. (6 more authors) (2016) Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden. In: Value in Health. ISPOR 19TH Annual European Congress, 29/10/2016-02/11/2016, Vienna, Austria. Elsevier , A556-A556.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Elsevier.
Dates:
  • Published (online): 31 October 2016
  • Published: November 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 10 May 2017 10:05
Last Modified: 10 May 2017 10:05
Status: Published
Publisher: Elsevier
Refereed: Yes
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export